DCDerek Chen

Derek Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Derek Chen has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Camille Torres

    Department of Urology Mount Sinai Hospital New York USA

    1 shared publication
  • Christina Milano

    From the Oregon Health & Science University, Department of Oregon Health & Science University, Department of Family Medicine, Portland (DC, JE, SL, TH, HH, NH, CM); Icahn School of Medicine at Mount Sinai, New York, NY (DC); Transgender Health Program, Oregon Health & Science University, Portland (CM)

    1 shared publication
  • Heather Holderness

    From the Oregon Health & Science University, Department of Oregon Health & Science University, Department of Family Medicine, Portland (DC, JE, SL, TH, HH, NH, CM); Icahn School of Medicine at Mount Sinai, New York, NY (DC); Transgender Health Program, Oregon Health & Science University, Portland (CM)

    1 shared publication
  • Jeremy Erroba

    From the Oregon Health & Science University, Department of Oregon Health & Science University, Department of Family Medicine, Portland (DC, JE, SL, TH, HH, NH, CM); Icahn School of Medicine at Mount Sinai, New York, NY (DC); Transgender Health Program, Oregon Health & Science University, Portland (CM)

    1 shared publication
  • Michaela Sljivich

    Department of Urology, Mount Sinai Hospital, New York, NY, USA

    1 shared publication
  • Miroslav Djordjevic

    Department of Urology, Mount Sinai Hospital, New York, NY, USA; Department of Urology and Surgery, University of Belgrade School of Medicine, Serbia

    1 shared publication

Latest Publications

  • Feasibility and Outcomes After Robot-Assisted Sigmoid Vaginoplasty for Gender Dysphoria

    by Michaela Sljivich, Camille Torres, Derek Chen, Tatyana Yatsenko, Peter Wiklund, Miroslav Djordjevic, Rajveer S. Purohit


  • Open Access

    The Effects of Testosterone on Cervicovaginal Cytology in Transgender and Gender-Diverse Individuals

    by Derek Chen, Jeremy Erroba, Shuling Liu, Tahlia Hodes, Heather Holderness, Nathalie Huguet, Christina Milano

    Background: The Papanicolaou (Papanicolaou) test is an effective and widely used cervical cancer screening procedure. Recommendations for cervical cancer screening do not incorporate patients’ gender identities nor gender-affirming hormone statuses in determining screening surveillance intervals and interpreting test results. This study assessed the association between testosterone and rates of abnormal Papanicolaou specimens and specimen adequacy by comparing testosterone-associated Papanicolaou specimens and nontestosterone Papanicolaou specimens among transgender and gender-diverse (TGD) patients. Methods: Retrospective electronic health record chart review of 211 TGD patients with cervixes, contributing 298 unique Papanicolaou tests, with a visit to a primary care clinic between 2012 and 2019. Primary outcomes included specimen quality (transformation zone [TZ] present, TZ absent, atrophic specimen, scant cellularity), presence of inflammation (yes/no), and cytology results (normal, abnormal, inadequate specimen). χ2 and t test were used to compare results between testosterone-associated Papanicolaou specimens (TAPS) and nontestosterone specimens (NTS). Results: A higher proportion of TAPS had missing TZ, showed atrophy, or had scant cellularity than NTPS (58.8% vs 33.5%; P < .001). In addition, a higher proportion of TAPS showed inflammation (16.0% vs 3.4%; P < .001). There was no significant difference in the proportion of abnormal results (ie, cytologic features concerning for dysplasia) between the TAPS and NTPS groups. Conclusions: Findings confirmed an association between testosterone usage and cytology specimen adequacy and quality. No association was found between testosterone usage and rates of abnormal results within our TGD population. More research is needed to disentangle the effect of missing TZ on risk of future cervical dysplasia among this younger population.